Publications by authors named "Beata Galuszka"
The study was a prospective, double-blind, placebo-controlled trial with patients diagnosed with LAR to HDMs and with concomitant asthma who underwent a 12-month treatment course of SLIT for HDM allergies. Seventeen patients were randomized to SLIT with the use of allergen extracts of and (50/50%) in SQ-HDM SLIT tablets and 15 patients were randomized to the placebo group. The total rhinitis score (TRSS), total asthma symptom score (TASS), combined total symptom score (TSS), total medication score (TMS), and FEV1 were analyzed.
View Article and Find Full Text PDFImpact of influenza vaccination on the risk of SARS-CoV-2 infection in a middle-aged group of people.
Hum Vaccin Immunother
September 2021
An observational study of a retrospective cohort was performed to assess the impact of influenza vaccination (IV) on the risk of SARS-CoV-2 infection in a population of middle-aged people for 8 weeks after IV and compared with an unvaccinated group. Data from 1098 middle-aged patients (53.7 ± 4.
View Article and Find Full Text PDFArticle Synopsis
- - The study investigates differences between local allergic rhinitis (LAR) and systemic allergic rhinitis (SAR), with a focus on patients allergic to birch, and compares them with those having non-allergic rhinitis (NAR).
- - A total of 65 patients were examined, with various tests conducted, including a nasal provocation test (NPT) and measurement of immune responses related to birch allergen.
- - Results showed an increase in nasal IgE levels in both LAR and SAR groups after NPT, but the study concluded that there are currently no definitive mechanisms that differentiate LAR from SAR.
Background: Efficacy of allergen immunotherapy (AIT) in local allergic rhinitis (LAR) is a new subject of research. The presence of asthmatic symptoms in patients with LAR in the context of AIT is unexplored.
Objective: The efficacy and safety of AIT in patients with LAR towards birch pollen were investigated.